EffTox, Wages & Tait, and BOIN12 - Efficacy & Toxicity DesignsUpdated 1 years ago

Kristian Brock

Rendered from A310-EfficacyToxicity.Rmd in escalation 0.2.3.
BOIN - Bayesian Optimal Interval DesignUpdated 1 years ago

Kristian Brock

Rendered from A230-BOIN.Rmd in escalation 0.2.3.
BOIN-COMB - Treatment Combination DesignsUpdated 1 years ago

Kristian Brock

Rendered from A360-Combinations.Rmd in escalation 0.2.3.
CRM - Continual Reassessment MethodUpdated 1 years ago

Kristian Brock

Rendered from A205-CRM.Rmd in escalation 0.2.3.
mTPI - Modified Toxicity Probability Interval DesignUpdated 1 years ago

Kristian Brock

Rendered from A220-mTPI.Rmd in escalation 0.2.3.
NBG - Neuenschwander, Branson & GsponerUpdated 1 years ago

Kristian Brock

Rendered from A207-NBG.Rmd in escalation 0.2.3.
TITE-CRM and TITE-NBG - Time-to-Event DesignsUpdated 1 years ago

Kristian Brock

Rendered from A280-TITE.Rmd in escalation 0.2.3.
TPI - Toxicity Probability Interval DesignUpdated 1 years ago

Kristian Brock

Rendered from A210-TPI.Rmd in escalation 0.2.3.
Using escalationUpdated 1 years ago

Kristian Brock

Rendered from A100-DoseSelectors.Rmd in escalation 0.2.3.
Comparing dose-escalation designs by simulationUpdated 2 years ago

Kristian Brock

Rendered from A710-SimulationComparison.Rmd in escalation 0.2.3.
Simulating dose-escalation trialsUpdated 2 years ago

Kristian Brock

Rendered from A700-Simulation.Rmd in escalation 0.2.3.
Working with dose-pathsUpdated 6 years ago

Kristian Brock

Rendered from A600-DosePaths.Rmd in escalation 0.2.3.